.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and effective medical countermeasures for public health. BARDA has been an excellent partner, across all levels from leadership to the project and technical teams with whom we work closely. As partners on a team, we work collaboratively to monitor, evaluate, and progress projects and help remove barriers that slow down the directive of Operation Warp Speed.”
Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions contributed to an editorial in the August issue of Pharmaceutical Technology on the pivotal role outsourcing partners have in the rapid development and production of COVID-19 vaccine candidates.
Read the full article here.
Article Details
Pharmaceutical Technology
Supplement: Outsourcing Resources
August 2020
Pages: s15–s17
Citation
J. Markarian, “All Hands on Deck for Fill/Finish of Vaccines and Therapeutics," Pharmaceutical Technology Outsourcing Resources Supplement (August 2020).
